0001144204-17-058212.txt : 20171113 0001144204-17-058212.hdr.sgml : 20171110 20171113134029 ACCESSION NUMBER: 0001144204-17-058212 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20170930 FILED AS OF DATE: 20171113 DATE AS OF CHANGE: 20171113 EFFECTIVENESS DATE: 20171113 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Foresite Capital Management II, LLC CENTRAL INDEX KEY: 0001594912 IRS NUMBER: 464028844 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-16497 FILM NUMBER: 171195003 BUSINESS ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 BUSINESS PHONE: 415-877-4887 MAIL ADDRESS: STREET 1: 600 MONTGOMERY STREET STREET 2: SUITE 4500 CITY: SAN FRANCISCO STATE: CA ZIP: 94111 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001594912 XXXXXXXX 09-30-2017 09-30-2017 false Foresite Capital Management II, LLC

600 Montgomery Street Suite 4500 San Francisco CA 94111

13F HOLDINGS REPORT 028-16497 N James B. Tananbaum 415-877-4887 /s/ James B. Tananbaum San Francisco CA 11-13-2017 0 12 246705 INFORMATION TABLE 2 infotable.xml Acceleron Pharma Inc. COM 00434H108 9134 244756 SH SOLE 244756 0 0 Aerie Pharmaceuticals, Inc. COM 00771V108 81294 1672714 SH SOLE 1672714 0 0 Aimmune Therapeutics, Inc. COM 00900T107 94709 3820462 SH SOLE 3820462 0 0 Alder BioPharmaceuticals, Inc. COM 014339105 12787 1043832 SH SOLE 1043832 0 0 Dermira, Inc. COM 24983L104 1583 58624 SH SOLE 58624 0 0 Epizyme, Inc. COM 29428V104 29396 1543108 SH SOLE 1543108 0 0 Insmed Incorporated COM 457669307 9363 300000 SH SOLE 300000 0 0 Juno Therapeutics, Inc. COM 48205A109 4037 90000 SH SOLE 90000 0 0 Jounce Therapeutics, Inc. COM 481116101 1868 119912 SH SOLE 119912 0 0 Loxo Oncology, Inc. COM 548862101 1317 14300 SH SOLE 14300 0 0 Orexigen Therapeutics, Inc. COM 686164302 1109 523132 SH SOLE 523132 0 0 Zafgen, Inc. COM 98885E103 108 30775 SH SOLE 30775 0 0